EPHX2 and depressive symptom measurement: Thus, this review discusses the role of sEH in neuropsychiatric disorders such as depression, autism spectrum disorder (ASD), schizophrenia, Parkinson’s disease (PD), and stroke as well as the potential mechanisms underlying the therapeutic effects of sEH inhibitors.